Elevated Maternal Cholesterol is Linked to a Co-expression Network of Neonatal Indole Metabolism and Birth Weight
The Developmental Origins of Health and Disease (DOHaD) hypothesis links intrauterine exposure to sub-optimal fetal development and later-life cardiometabolic health. In 56 mother-newborn pairs, we quantified 389 newborn cord-blood metabolites by LC-MS/MS and recorded 24 clinical variables. With weighted co-expression network analysis, we identified "module 05", comprising birth weight and metabolites enriched for the "gut-liver indole metabolism" pathway (indole, indole-3-pyruvic acid, and indole-3-lactic acid). Multivariable regression revealed that each 1-SD higher "module 05" expression score was associated with -0.26 [95% CI: -0.51, -0.01] SD lower 3<sup>rd</sup>-trimester total cholesterol (P = 0.039), adjusting for newborn and maternal covariates. This supports a coordinated newborn pattern of lower birth weight and lower cord-blood indole metabolite abundance in pregnancy cases with higher late-pregnancy total cholesterol. Stratified analyses further suggested that, among pregnancies with maternal supraphysiological hypercholesterolaemia (MSPH; 3<sup>rd</sup>-trimester total cholesterol ≥280 mg/dL), higher maternal age and higher 1<sup>st</sup>-trimester systolic blood pressure were accompanied by lower "module 05" score, whereas these associations were not observed in non-MSPH pregnancies. Complementary regression analysis associated each tertile higher cord-blood indole-3-propionic acid (IPA) with -9.09 [-17.45, -0.72] mg/dL lower 1<sup>st</sup>-trimester cholesterol (P = 0.038). Separately, each 1-tertile higher IPA was linked to 192.22 [55.44, 329.00] gram higher newborn weight (P = 0.008). Both 1<sup>st</sup>- and 3<sup>rd</sup>-trimester total cholesterols were positively associated with higher cord-blood oxidative stress (8-hydroxy-2'-deoxyguanosine; 8-OHdG). In conclusion, maternal cholesterol level varies with cord-blood indole metabolites and birth weight, suggesting a potential shared metabolic axis modifiable by maternal cholesterol level in mother-newborn pairs.
Authors
- Poh Leong Lim
- Chester Lee Drum (ORCID: https://orcid.org/0000-0001-6327-4584)
- Reyna Peñailillo (ORCID: https://orcid.org/0000-0001-5300-1208)
- Claudette Cantin (ORCID: https://orcid.org/0000-0002-0732-1881)
- L. H. Wu (ORCID: https://orcid.org/0000-0003-1965-9895)
- Ignacio Valenzuela (ORCID: https://orcid.org/0000-0002-7277-2152)
- Mahesh Choolani (ORCID: https://orcid.org/0000-0001-8336-0973)
- Lara J. Monteiro (ORCID: https://orcid.org/0000-0003-2078-380X)
- Jielin Yang
- Ling-Jun Li
- Sebastian Illanes
- Matthew W. Kemp
- Leroy Sivapragasam Pakkiri
- Andrea Leiva
Institutions
- Agency for Science, Technology and Research (SG)
- National University of Singapore (SG)
- University Health System (US)
- San Sebastián University (CL)
- Star Technology and Research (United States) (US)
- National University Heart Centre Singapore (SG)
- Women and Infants Research Foundation (AU)
- Universidad de Los Andes (BO)
- National University Health System (SG)
- Kitasato University (JP)
Publication Details
- Journal
- American Journal of Physiology-Heart and Circulatory Physiology
- Published
- 2026-03-23
- DOI
- https://doi.org/10.1152/ajpheart.00854.2025
- Primary Topic
- Birth, Development, and Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00